Shareholders Reject Executive Pay, Elect Directors Amidst Financial Challenges
SAM is trading near its 52-week low of $167.01 (0.2% above the low).
Summary
Boston Beer Company shareholders rejected the advisory vote on executive compensation at the annual meeting, signaling dissatisfaction amidst recent financial losses and a significant litigation verdict.
Key Events · Corporate Governance and Compliance · SAM
-
Shareholders Reject Executive Compensation
The advisory vote on executive compensation failed, with 3,250,742 votes against compared to 2,418,918 votes for, indicating significant shareholder dissatisfaction.
-
Class A Directors Elected Amidst Dissent
Three Class A Directors were elected, though two (Meghan V. Joyce and Joseph H. Jordan) received more 'withheld' votes than 'for' votes, reflecting some shareholder dissent.
-
Board Committee Appointments
The Board appointed independent Directors to the Audit, Compensation, and Nominating/Governance Committees, and reappointed Julio N. Nemeth as Lead Director.
Analysis · SAM · Manufacturing
The failure of the advisory "Say-on-Pay" vote indicates significant shareholder discontent with executive compensation practices, especially following a substantial net loss in Q1 and a large jury verdict against the company. This non-binding vote puts pressure on the Board's Compensation Committee to review and potentially revise executive pay structures. The stock is also trading near its 52-week low, amplifying shareholder frustration.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 29.9% of the 1678 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.25%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SAM was trading at $167.36 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $167.01 to $264.46. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.